Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Different-dose tranexamic acid for hemostasis after posterior lumbar surgery
ChiCTR1900026582Phase 4Recruiting
- Sponsor
- The Affiliated Hospital of Xuzhou Medical University
- Start
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of tranexamic acid in Herniated Lumbar Disk, lumbar spinal stenosis (LSS) and lumbar spondylolisthesis (4 arms), sponsored by The Affiliated Hospital of Xuzhou Medical University. Primary endpoints: Length of operation, Intraoperative blood loss and 3 more. Started Oct 2019; status: recruiting.
02
Drugs
tranexamic acid
03
Conditions
Herniated Lumbar Disklumbar spinal stenosis (LSS)lumbar spondylolisthesis
Beyond the preview
Go deeper on ChiCTR1900026582.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900026582.